GYRE THERAPEUTICS INC (GYRE) Stock Balance Sheet
NASDAQ:GYRE - US4037831033 - Common Stock
7.69 USD
+0.11 (+1.45%)
7.69 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 36.49M | 11.81M | 33.51M | 21.70M | 44.30M | |||
| Marketable Securities | 17.87M | 14.86M | N/A | 0.00 | 2.50M | |||
| Receivables | 25.36M | 29.15M | 16.84M | 5.00M | 1.80M | |||
| Inventories | 8.86M | 6.34M | 4.28M | N/A | N/A | |||
| Other Current Assets | 2.70M | 2.63M | 2.59M | 1.50M | 2.80M | |||
| Total Current Assets | 91.28M | 64.79M | 57.22M | 28.20M | 51.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 24.90M | 25.70M | 23.78M | 100.00K | 3.70M | |||
| Investments And Advances | 23.23M | 26.27M | 23.43M | N/A | 0.00 | |||
| Intangibles | 4.96M | 273.00K | 205.00K | N/A | N/A | |||
| Other Non-Current Assets | 8.27M | 8.38M | 7.18M | 200.00K | 500.00K | |||
| Total Non-Current Assets | 61.36M | 60.62M | 59.32M | 200.00K | 4.20M | |||
| TOTAL ASSETS | 152.65M | 125.41M | 116.54M | 28.40M | 55.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 15.55M | 11.33M | 12.14M | 4.10M | 7.50M | |||
| Accounts Payable | 71.00K | 108.00K | 355.00K | 200.00K | 6.40M | |||
| Other Current Liabilities | 1.30M | 8.08M | 7.55M | 12.60M | 200.00K | |||
| Total Current Liabilities | 16.92M | 19.52M | 20.05M | 16.80M | 14.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 6.28M | 7.49M | 18.02M | 0.00 | 400.00K | |||
| Total Non-Current Liabilities | 43.70M | 42.57M | 47.80M | 0.00 | 400.00K | |||
| TOTAL LIABILITIES | 60.62M | 62.09M | 67.84M | 16.80M | 14.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -67.22M | -70.36M | -82.44M | -410.90M | -402.70M | |||
| Additional Paid In Capital | 161.44M | 136.19M | 68.18M | 389.20M | 443.80M | |||
| Minority Interest | 37.42M | 35.08M | 29.78M | N/A | N/A | |||
| Common Shares | 91.00K | 86.00K | 64.60M | 33.30M | 0.00 | |||
| Other Shareholders' Equity | -2.29M | -2.60M | -1.64M | N/A | 0.00 | |||
| Shares Outstanding | 90.82M | 86.31M | 76.60M | 2.50M | 2.10M | |||
| Tangible Book Value per Share | 0.96 | 0.73 | -0.21 | -8.68 | 19.57 | |||
| Total Shareholders' Equity | 92.03M | 63.32M | 48.70M | 11.60M | 41.10M | |||
| TOTAL LIABILITIES AND EQUITY | 152.65M | 125.41M | 116.54M | 28.40M | 55.70M | |||
| Statistics | ||||||||
| Current Ratio | 5.40 | 3.32 | 2.85 | 1.68 | 3.63 | |||
| Return On Assets (ROA) | 2.73% | 9.64% | -79.74% | -29.01% | -157.86% | |||
| Return On Equity (ROE) | 4.53% | 19.09% | -190.84% | -71.03% | -213.94% | |||
| Return On Invested Capital (ROIC) | 5.30% | 11.81% | 15.35% | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 8.85% | 15.79% | 23.52% | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 9.42% | 15.85% | 23.59% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.23